{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T17:23:35Z","timestamp":1794936215303,"version":"4.9.1"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11]]},"abstract":"<jats:p>Hemophagocytic lymphohistocytosis (HLH) is a potentially fatal hyperinflammatory syndrome that is characterized by proliferation of histiocytes and hemophagocytosis in different organs. The diagnostic criteria include fever, hepatosplenomegaly, bicytopenia, high serum ferritin level, decreased natural killer cell activity, elevated soluble CD25 level, high serum fasting triglyceride level or low fibrinogen level, and hemophagocytosis in the bone marrow, spleen, or lymph nodes. HLH can be classified as primary and secondary. Secondary HLH can be related to infections. Here we report a case of Brucella-related HLH, which has been rarely reported in the literature.<\/jats:p>","DOI":"10.1097\/mph.0000000000000849","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T16:20:37Z","timestamp":1496247637000},"page":"e501-e503","source":"Crossref","is-referenced-by-count":9,"title":["Secondary Hemophagocytic Lymphohistocytosis in a Child With Brucellosis"],"prefix":"10.1097","volume":"39","author":[{"given":"Esra","family":"Pekpak","sequence":"first","affiliation":[{"name":"Pediatric Hematology and Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benhur","family":"Sirvan Cetin","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Disease, Gaziantep Cengiz Gokcek Maternity and Children Hospital, Gaziantep, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0140-6736(00)61951-7","article-title":"Histiocytic medullary reticulosis","volume":"2","author":"Scott","year":"1939","journal-title":"Lancet"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.blre.2007.05.001","article-title":"Hemophagocytic syndromes","volume":"21","author":"Janka","year":"2007","journal-title":"Blood Rev"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/humu.20274","article-title":"Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A","volume":"27","author":"Zur Stadt","year":"2006","journal-title":"Hum Mutat"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1136\/jmg.2005.035253","article-title":"Spectrum and clinical implications of syntaxin 11 gene mutations in familial haemophagocytic lymphohistiocytosis: association with disease-free remissions and haematopoietic malignancies","volume":"43","author":"Rudd","year":"2006","journal-title":"J Med Genet"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1568-9972(03)00091-0","article-title":"Pathogenesis of hemophagocytic syndrome","volume":"3","author":"Larroche","year":"2004","journal-title":"Autoimmun Rev"},{"key":"R7-20230918","first-page":"803","article-title":"Pancytopenia, a rare hematologic manifestation of brucellosis in children","volume":"26","author":"Karakukcu","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/08880018.2010.536298","article-title":"An analysis of children with brucellosis associated with pancytopenia","volume":"28","author":"Akbayram","year":"2011","journal-title":"Pediatr Hematol Oncol"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1684-1182(10)60025-4","article-title":"A rare hematological manifestation of brucellosis: reactive hemophagocytic syndrome","volume":"43","author":"Erduran","year":"2010","journal-title":"J Microbiol Immunol Infect"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ijid.2009.06.031","article-title":"Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature","volume":"14","author":"Buzgan","year":"2010","journal-title":"Int J Infect Dis"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5799\/ahinjs.02.2014.01.0123","article-title":"A brucellosis case presenting with vesicular and maculopapular rash and febrile neutropenia","volume":"4","author":"Caylak","year":"2014","journal-title":"J Microbiol Infect Dis"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1600-0609.1986.tb01746.x","article-title":"Pancytopenia and other haematological findings in brucellosis","volume":"36","author":"Aysha","year":"1986","journal-title":"Scand J Haematol"},{"key":"R13-20230918","first-page":"63","article-title":"Hematologic changes in brucellosis cases in Turkey","volume":"52","author":"Akdeniz","year":"1998","journal-title":"Acta Med Okayama"},{"key":"R14-20230918","first-page":"168","article-title":"Succesful treatment of reactive hemophagocytic syndrome with cylosporin A and intravenous immunoglobulin","volume":"42","author":"Erduran","year":"2000","journal-title":"Turk J Pediatr"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S1473-3099(07)70286-4","article-title":"Human brucellosis","volume":"7","author":"Franco","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1517\/14656566.2.9.1437","article-title":"Recent developments in the management of hemophagocytosis","volume":"2","author":"Shinsaku","year":"2001","journal-title":"Expert Opin Pharmacother"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201711000-00037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T05:03:38Z","timestamp":1695013418000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201711000-00037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000849","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}